2023
DOI: 10.1016/j.jhin.2023.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Finally, we were unable to directly compare the costs of our approach compared to no use of WGS or WGS surveillance because the cost estimate was beyond the scope of this work. 16 , 32 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Finally, we were unable to directly compare the costs of our approach compared to no use of WGS or WGS surveillance because the cost estimate was beyond the scope of this work. 16 , 32 …”
Section: Discussionmentioning
confidence: 99%
“… 8 Although WGS surveillance may identify all genetically related COVID-19 cases, it has practical limitations including resource costs, experienced staff, and availability. 16 , 17 …”
mentioning
confidence: 99%